Gene: VPS35L
Official Full Name: VPS35 endosomal protein sorting factor likeprovided by HGNC
Gene Summary: Involved in Golgi to plasma membrane transport and endocytic recycling. Located in endosome. Implicated in Ritscher-Schinzel syndrome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12656 | VPS35L Knockout cell line (HeLa) | Human | VPS35L | 1:3~1:6 | Negative | Online Inquiry |
KO12657 | VPS35L Knockout cell line (HCT 116) | Human | VPS35L | 1:2~1:4 | Negative | Online Inquiry |
KO12658 | VPS35L Knockout cell line (HEK293) | Human | VPS35L | 1:3~1:6 | Negative | Online Inquiry |
KO12659 | VPS35L Knockout cell line (A549) | Human | VPS35L | 1:3~1:4 | Negative | Online Inquiry |
VPS35L Gene Knockout Cell Lines are expertly developed biological tools designed to facilitate the exploration of the VPS35L gene's role in cellular processes and disease mechanisms. VPS35L, a member of the retromer complex, is integral to the intracellular trafficking of proteins, particularly during retrograde transport from endosomes to the trans-Golgi network. By providing a complete knockout of the VPS35L gene, these cell lines enable researchers to assess the physiological and pathological consequences of its absence, thereby elucidating its functional impacts on cellular homeostasis and signaling pathways.
The primary mechanism of action behind the VPS35L knockout lies in disrupting the retromer complex's integrity, leading to impaired protein sorting and increased accumulation of mislocalized proteins within the endosomal system. This disruption not only provides insights into neurodegenerative diseases but also signals transduction discrepancies that may contribute to cancer progression.
The scientific relevance of VPS35L Gene Knockout Cell Lines extends to both fundamental research and clinical applications, such as drug development and therapeutic targeting in conditions associated with retromer dysfunction. Compared to alternative models, these specialized cell lines offer a precise tool for studying the specific effects of VPS35L deficiency, enabling more refined experimental designs and results.
Researchers and clinicians will find great value in these cell lines, as they provide a robust platform to better understand cellular mechanisms and potential disease pathways. The unique ability to generate consistent and replicable results positions VPS35L Gene Knockout Cell Lines as an invaluable asset in the quest for novel insights in cell biology and therapeutic advancements.
Our company prides itself on delivering high-quality biological products backed by rigorous scientific research and a commitment to innovation, ensuring that our customers have access to state-of-the-art tools tailored for their research needs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.